Inozyme Pharma, Inc. (INZY)
USD 2.76
(-6.12%)
USD 2.76
(-6.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.29 Million | 1.17 Million | 1.05 Million | 217 Thousand | 83 Thousand | 26 Thousand |
| Gross Profit | -1.29 Million | -1.17 Million | -1.05 Million | -217 Thousand | -83 Thousand | -26 Thousand |
| Operating Expenses | 75.64 Million | 68.67 Million | 56.64 Million | 57.04 Million | 20.8 Million | 11.59 Million |
| Selling, General and Administrative Expenses | 20.79 Million | 20.82 Million | 18.92 Million | 10.54 Million | 4.58 Million | 3.49 Million |
| Research and Development Expenses | 54.84 Million | 47.84 Million | 37.72 Million | 46.49 Million | 16.22 Million | 8.09 Million |
| Other Expenses | - | -319 Thousand | -189 Thousand | 247 Thousand | -24 Thousand | 4.34 Million |
| Cost and Expenses | 75.64 Million | 68.67 Million | 56.64 Million | 57.04 Million | 20.8 Million | 11.59 Million |
| Operating Income | -75.64 Million | -68.67 Million | -56.64 Million | -57.04 Million | -20.8 Million | -11.59 Million |
| Interest Expense | 3.33 Million | - | - | - | - | - |
| Income Tax Expense | - | -1.61 Million | -211 Thousand | -587 Thousand | -1.1 Million | 4.62 Million |
| Earnings before Tax | -71.16 Million | -67.06 Million | -56.62 Million | -56.42 Million | -19.72 Million | -6.96 Million |
| Net Income | -71.16 Million | -65.44 Million | -56.41 Million | -55.83 Million | -18.61 Million | -6.96 Million |
| Earnings Per Share Basic | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
| Earnings Per Share Diluted | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
| Weighted Average Shares Outstanding | 51.83 Million | 37.76 Million | 23.55 Million | 23.38 Million | 15.15 Million | 15.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.83 Million | 37.76 Million | 23.55 Million | 23.38 Million | 15.15 Million | 15.13 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -74.81 Million | -65.88 Million | -55.97 Million | -56.82 Million | -20.72 Million | -11.56 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 1.97 Million | - |
| Cost of Revenue | - | 188 Thousand | 182 Thousand | 1.29 Million | 306 Thousand | 333 Thousand |
| Gross Profit | - | -188 Thousand | -182 Thousand | -1.29 Million | 1.67 Million | -333 Thousand |
| Operating Expenses | 24.85 Million | 27.47 Million | 24.34 Million | 74.35 Million | 22.5 Million | 18.07 Million |
| Selling, General and Administrative Expenses | 4.96 Million | 5.9 Million | 5.23 Million | - | 4.69 Million | 4.73 Million |
| Research and Development Expenses | 19.89 Million | 21.57 Million | 19.11 Million | - | 17.8 Million | 13.34 Million |
| Other Expenses | - | -3000.00 | -51 Thousand | - | 14 Thousand | 20 Thousand |
| Cost and Expenses | 24.85 Million | 27.66 Million | 24.34 Million | 75.64 Million | 22.8 Million | 18.07 Million |
| Operating Income | -24.85 Million | -27.66 Million | -24.34 Million | -75.64 Million | -22.8 Million | -18.07 Million |
| Interest Expense | -1.41 Million | 1.39 Million | -1.32 Million | 3.33 Million | 3.33 Million | - |
| Income Tax Expense | - | - | -182 Thousand | - | 2.21 Million | -208 Thousand |
| Earnings before Tax | -24.57 Million | -27.03 Million | -23.34 Million | -71.16 Million | -21.54 Million | -16.63 Million |
| Net Income | -24.57 Million | -27.03 Million | -23.34 Million | -71.16 Million | -21.54 Million | -16.63 Million |
| Earnings Per Share Basic | -0.39 | -0.44 | -0.38 | - | -0.35 | -0.29 |
| Earnings Per Share Diluted | -0.39 | -0.44 | -0.38 | - | -0.35 | -0.29 |
| Weighted Average Shares Outstanding | 63.27 Million | 61.94 Million | 61.77 Million | 51.83 Million | 61.76 Million | 56.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.27 Million | 61.94 Million | 61.77 Million | 51.83 Million | 61.76 Million | 56.75 Million |
| Gross Margin | - | - | - | - | 0.85 | - |
| EBIT Margin | - | - | - | - | -11.39 | - |
| Profit Margin | - | - | - | - | -10.90 | - |
| EBITDA | -24.85 Million | -27.47 Million | -24.34 Million | - | -22.5 Million | -18.07 Million |
| Earnings Before Tax Margin | - | - | - | - | -11.54 | - |
QYOUF
RNT
300308
WLFD
301163
1245